Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04123795
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque PsoriasisMixed Guttate/Plaque Psoriasis
UCB Biopharma SRL 49
Not applicableStudy completedNCT03925441
What this trial is testing

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

Who this might be right for
Psoriasis
AbbVie 2
Large-scale testing (Phase 3)Active Not RecruitingNCT06425549
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 176
Post-approval studies (Phase 4)Active Not RecruitingNCT03240809
What this trial is testing

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 2
Large-scale testing (Phase 3)Study completedNCT01090427
What this trial is testing

The Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 110
Not applicableStudy completedNCT03791216
What this trial is testing

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment

Who this might be right for
Psoriasis
Northwestern University 62
Not applicableNot Yet RecruitingNCT07451626
What this trial is testing

Clinical, Epidemiologic, and Therapeutic Characterization of Pediatric Psoriasis in the Costa Rican Social Security System

Who this might be right for
Pediatric Psoriasis
Caja Costarricense de Seguro Social 300
Post-approval studies (Phase 4)Study completedNCT02186665
What this trial is testing

Plaque Psoriasis Study in Pediatric Subjects

Who this might be right for
Plaque Psoriasis
Galderma R&D 19
Large-scale testing (Phase 3)Study completedNCT04435600
What this trial is testing

Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Who this might be right for
Psoriasis
AbbVie 139
Not applicableStudy completedNCT05803187
What this trial is testing

Clinical Study of Stage IV Psoriasis in Children With Geleli

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 80
Not applicableStudy completedNCT03051347
What this trial is testing

Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

Who this might be right for
Atopic DermatitisIchthyosisPsoriasis
Northwestern University 943
Post-approval studies (Phase 4)Looking for participantsNCT03987763
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 45
Large-scale testing (Phase 3)Active Not RecruitingNCT05172726
What this trial is testing

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Who this might be right for
Plaque Psoriasis
Organon and Co 58
Large-scale testing (Phase 3)Study completedNCT03701763
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 245
Not applicableStudy completedNCT05215561
What this trial is testing

Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP

Who this might be right for
Psoriasis VulgarisPsoriatic ArthritisPustular Psoriasis
Novartis Pharmaceuticals 36
Post-approval studies (Phase 4)Study completedNCT01766440
What this trial is testing

PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Galderma R&D 18
Post-approval studies (Phase 4)Study completedNCT02125279
What this trial is testing

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Galderma R&D 54
Large-scale testing (Phase 3)Looking for participantsNCT06663332
What this trial is testing

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Who this might be right for
Crohns DiseaseColitis, UlcerativeArthritis, Psoriatic+1 more
Janssen Research & Development, LLC 196
Large-scale testing (Phase 3)Not Yet RecruitingNCT06833307
What this trial is testing

The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis

Who this might be right for
Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT02576678
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 42
Next Page